2000 Saab 9 3 Turbo Convertible on 2040-cars

Auto blog

Junkyard Gem: 1989 Saab 9000 Turbo

Saab got a lot of sales out of its 99 and 99-based 900 models, but a bigger and more modern car became necessary in order to compete with other European manufacturers in the executive-car market. This car was the 9000, and examples are getting very hard to find nowadays. Here's a 200,000-mile turbocharged 1989 Saab 9000 in a San Francisco Bay Area self-service wrecking yard. Other than Mercedes-Benzes and Volvo 240s, I don't see many junkyard 1980s European cars with better than 200,000 miles on the clock. The owner or owners of this Saab loved it enough to keep it in nice shape for a good 30 years, and it drove more than 7,000 miles on average during each year of its life. The engine is the same 160-horsepower turbocharged Saab H that went into the 1989 Saab 900 Turbo. This engine is descended from the Triumph Slant-4, which Americans knew best as the power under the hood of the Triumph TR-7. Members of this engine family remained in production from 1968 through 2009. It has the five-speed manual transmission, which was starting to become an unusual transmission choice for U.S. car buyers by 1989 — even in Saabs. The Scania badging on Saabs went away after 1995. I see plenty of Saab 900s during my junkyard wanderings, but 9000s aren't so easy to find in the big U-Wrench yards in 2018. I'm not sure what's going on with the fabric in this car's door-panel inserts. Saab went with the same ignition-switch location as everybody else with the 9000, rather than the "traditional" spot between the front seats. Naturally, Saab purists were so outraged by this that they ordered another round of surstromming and swore to stick with their two-stroke 96s for the next 30 years. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Ballet in 3 acts for 8 SAAB 9000 Turbos. Featured Gallery Junked 1989 Saab 9000 Turbo View 18 Photos Auto News Saab Automotive History

Look familiar? NEVS 9-3, 9-3X are Saab-derived EVs for China

National Electric Vehicle Sweden (NEVS) have been working on creating EVs based on its Saab assets for years. We heard back in 2015 that we'd have an EV based on the 9-3 this year, and now we're finally getting to see the results. NEVS has unveiled its 9-3 and 9-3X EV concepts, which it will use in a mobility project in Tianjin, China. NEVS is showing the 9-3 EVs at CES Asia in Shanghai on June 7-9, where it will also provide more details about the cars, its Tianjin project, and future plans for the brand. As for Tianjin, NEVS will provide the cars and the services for carsharing and ride-hailing programs in the city. For that project, NEVS is collaborating with Tianjin Binhai Hi-tech Industrial Development Area (THT), which is the industrial park where its shared factory (with joint venture partner Dongfeng) and R&D center are located. NEVS President Mattias Bergman says, "We are excited by this great opportunity to develop smart, sustainable mobility solutions together with a progressive city as Tianjin, and develop them in full scale with real people in real life situations, with the vision to create a future integrated urban mobility solution." As for the 9-3 EVs, they're not much different in appearance from the GM-era Saabs, but they have NEVS badging (NEVS doesn't have rights to the Saab trademark). They have a driving range of about 186 miles, offer in-car Wi-Fi, smartphone connectivity, and can get over-the-air software updates. NEVS says the cars are equipped with a "world-class" cabin air filter, which helps keep harmful particulates out of the car (important in the polluted urban centers China is working to improve). They're being built in China, and are expected to hit the roads there in 2018. Related Video:

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.